Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 12 of 12 for “"Liposome stability"”.

  1. Liposomes in drug delivery: stability, interfacial interaction and drug release

    Liposomes are used as biocompatible carriers of drugs, peptides, proteins, plasmic DNA, antisense oligonucleotides or ribozymes, for pharmaceutical, cosmetic, and biochemical purposes. They are considered as effective drug delivery systems due to their colloidal size, easily controllable surface …

    adelaide Repository record for Liposomes in drug delivery: stability, interfacial interaction and drug release (opens in a new tab)

  2. Evaluation of Physical and Chemical Stability in Liposomes Composed of Mixed Phospholipids

    Liposomes, spherical vesicles composed of lipid bilayers, are widely used in drug delivery due to their biocompatibility, biodegradability, and ability to interact with biological membranes. Despite these advantages, liposomes remain moderately unstable systems, highly susceptible to environmental …

    bucknell Repository record for Evaluation of Physical and Chemical Stability in Liposomes Composed of Mixed Phospholipids (opens in a new tab)

  3. Cysteine and Iron (II) Responsive Lipid Switches to Enhance Liposomal Cell Delivery Using a Charge-Balance Strategy

    Liposomes are useful platforms for drug delivery because their amphiphilic lipid structures enable them to self-assemble into bilayer vesicles that can encapsulate cargo and interact with biological membranes. However, effective delivery requires balancing liposome stability prior to reaching the …

    ut-knoxville Repository record for Cysteine and Iron (II) Responsive Lipid Switches to Enhance Liposomal Cell Delivery Using a Charge-Balance Strategy (opens in a new tab)

  4. Lipid Encapsulation of Curcumin and Ibuprofen for Improving Drug Delivery

    … and can bind to proteins, leading chemical instability, rapid elimination, and fast liver metabolism, while ibuprofen has poor solubility and absorption in small intestine. For this purpose, ibuprofen and curcumin have been co-encapsulated inside liposome. DPPC …

    whiterose Download PDF for Lipid Encapsulation of Curcumin and Ibuprofen for Improving Drug Delivery (opens in a new tab)

  5. Adapaleno įterpimo į liposomas ir jo atpalaidavimo tyrimas /

    … is titled “Study of adapalene encapsulation into liposomes and it’s release.” The supervisor of the research is Rima Budvytytė PhD. Research was carried out at the Department of Bioelectrochemistry and Biospectroscopy at the Institute of Biochemistry in the Life Sciences Center of Vilnius …

    vilnius Repository record for Adapaleno įterpimo į liposomas ir jo atpalaidavimo tyrimas / (opens in a new tab)

  6. Development and optimization of powders containing liposomes for pulmonary administration

    … and therapeutic efficiency. To address this, liposomes have emerged as attractive carriers, enabling the encapsulation of active pharmaceutical ingredients, their protection from degradation and improved bioavailability, although their limited aqueous stability remains a major challenge. In …

    liege Repository record for Development and optimization of powders containing liposomes for pulmonary administration (opens in a new tab) Download PDF for Development and optimization of powders containing liposomes for pulmonary administration (opens in a new tab)

  7. Engineering liposomal systems to develop solubility enhancing technology

    … parameters which control the efficacy of liposomes as delivery systems to enhance the delivery of poorly soluble drugs. Preliminary studies focused on the drug loading of ibuprofen within vesicle systems. Initially both liposomal and niosomal formulations were screened for their …

    aston Download PDF for Engineering liposomal systems to develop solubility enhancing technology (opens in a new tab)

  8. Optimization of antibiotic-loaded liposomes for inhalation to improve lung infection treatment

    … for the pulmonary delivery of apramycin-loaded liposomes in dry powder form with desirable physicochemical characteristics such as: size (< 150 nm), zeta potential (> 50 mV), polydispersity index (PDI) (≤ 0.3), encapsulation efficiency (EE) (>50% ), powder particle sizes (≤ 5 μm), glass …

    qu-belfast Repository record for Optimization of antibiotic-loaded liposomes for inhalation to improve lung infection treatment (opens in a new tab) Embargoed until 2027-07-31

  9. CHARACTERIZATION OF THERMOSENSITIVE HYBRID ARCHAEOSOMES AND DPA-CY3[22,22]/POPC LIPOSOMES AND IN VITRO EVALUATION OF THEIR POTENTIAL USEFULNESS IN TARGETED DELIVERY AND CONTROLLED RELEASE

    … tract and the heart. Encapsulating DXO into liposomes as done in the first FDA-approved liposomal DXO, Doxil, minimizes toxicity and improves the half-life, allowing more opportunities for the drug to reach the tumor. While liposomal DXO is in the market with an annual sale of approximately …

    temple Repository record for CHARACTERIZATION OF THERMOSENSITIVE HYBRID ARCHAEOSOMES AND DPA-CY3[22,22]/POPC LIPOSOMES AND IN VITRO EVALUATION OF THEIR POTENTIAL USEFULNESS IN TARGETED DELIVERY AND CONTROLLED RELEASE (opens in a new tab)

  10. Interfacing Liposomes with Metal Ions and Metal Oxides: Coordination Chemistry, Surface Forces and Membrane Integrity

    Liposomes are self-closed vesicles composed of lipid bilayer walls that have been widely used as models for cell membranes and drug delivery vehicles. One interesting research direction is to study the interactions of membranes with various ions, molecules and materials. Among them, metal ions and …

    waterloo Repository record for Interfacing Liposomes with Metal Ions and Metal Oxides: Coordination Chemistry, Surface Forces and Membrane Integrity (opens in a new tab)

  11. Λιποσώματα ως φορείς αλκυλολυσοφωσφολιπιδίων και μιτομυκίνης C

    ΣΤΗΝ ΠΑΡΟΥΣΑ ΜΕΛΕΤΗ ΠΡΟΣΠΑΘΗΣΑΜΕ ΝΑ ΕΝΣΩΜΑΤΩΣΟΥΜΕ ΔΥΟ ΠΡΟΔΡΟΜΕΣ ΜΟΡΦΕΣ ΤΗΣ ΜΥΤΟΜΥΚΙΝΗΣ C (ΜΜC) ΣΕ ΛΙΠΟΣΩΜΑΤΑ ΜΕ ΣΤΟΧΟ ΤΗΝ ΑΛΛΑΓΗ ΤΩΝ ΦΑΡΜΑΚΟΚΙΝΗΤΙΚΩΝ ΙΔΙΟΤΗΤΩΝ ΤΟΥ ΦΑΡΜΑΚΟΥ,ΩΣΤΕ ΤΕΛΙΚΑ ΝΑ ΥΠΑΡΞΕΙ ΜΕΙΩΣΗ ΤΗΣ ΣΥΣΤΗΜΑΤΙΚΗΣ ΤΟΥ ΤΟΞΙΚΟΤΗΤΑΣ.ΤΑ ΛΙΠΟΣΩΜΑΤΑ ΠΕΡΙΛΑΜΒΑΝΑΝ ΑΚΟΜΑ ΣΤΗ ΔΟΜΗ ΤΟΥΣ ΚΙ ΕΝΑΝ ΑΛΛΟ …

    greece Repository record for Λιποσώματα ως φορείς αλκυλολυσοφωσφολιπιδίων και μιτομυκίνης C (opens in a new tab)